China SXT Pharmaceuticals, Inc. (SXTC)

Nasdaq: SXTC · Pharmaceutical Preparations · Taizhou · filing with the SEC since 2017

Grade3.3

◀ Past 2.5● Present 4.1▶ Future 3.2

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in March.

Income statement, by fiscal year, newest first
Fiscal year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Report filed	Jul 1, 2026	Jul 31, 2025	Aug 13, 2024	Jul 31, 2023	Jul 18, 2022	Aug 13, 2021	Jul 31, 2020	Aug 15, 2019	·	·
Revenue	1,138,052	1,740,907	1,928,497	1,971,679	2,602,281	4,777,573	5,162,268	7,012,026	7,019,243	4,881,523
Cost of revenue	889,350	1,373,480	1,374,526	1,545,408	1,350,638	1,938,023	2,458,566	2,400,491	3,617,748	2,569,522
Gross profit	248,702	367,427	553,971	426,271	1,251,643	2,839,550	2,703,702	4,611,535	3,401,495	2,312,001
Research and development	·	·	184,194	200,717	367,005	·	·	·	·	·
Sales and marketing	244,185	289,859	433,566	387,452	924,538	1,587,333	·	·	·	·
General and administrative	7,127,450	2,758,047	2,635,622	5,646,328	5,516,778	3,449,293	2,461,535	1,236,546	1,256,747	565,455
Total operating expenses	7,371,635	3,047,906	3,069,188	6,033,780	6,441,316	5,036,626	4,044,819	2,842,043	1,769,229	709,819
Operating income	-7,122,933	-2,680,479	-2,515,217	-5,607,509	-5,189,673	-2,197,076	-1,341,117	1,769,492	1,632,266	1,602,182
Interest expense	62,965	648,221	544,279	476,776	36,695	1,615,440	3,348,790	5,174	779	40,390
Other income (expense), net	·	·	·	149,513	-181,581	871,650	-73,771	27,141	-3,803	18,403
Total non-operating income (expense)	917,848	-623,173	-583,315	-327,263	-218,276	-743,790	-9,048,477	21,967	-4,582	-21,987
Income before income taxes	-6,205,085	-3,303,652	-3,098,532	-5,934,772	-5,407,949	-2,940,866	-10,389,594	1,791,459	1,627,684	1,580,195
Income tax expense	·	·	·	·	328,146	-192,683	-101,722	252,232	440,103	395,049
Net income including non-controlling interests	·	·	·	·	-5,736,095	-2,748,183^r	-10,287,872	1,539,227	·	·
Net income	-6,205,085	-3,303,652	-3,098,532	-5,934,772	-5,736,095	-2,748,183	-10,287,872	1,539,227	1,187,581	1,185,146
Earnings per share, basic	-9.13	-348.17^r	-4,285.66^r	-26,675.55^rb	-165,501.60^rb	-114,570.00^rb	998,460.00^b	2,250.00^b	1,770.00^b	1,770.00^b
Earnings per share, diluted	-9.13	-348.17^r	-4,285.66^r	-26,675.55^rb	-165,501.60^rb	-114,570.00^b	·	2,250.00^b	1,770.00^b	1,770.00^b
Earnings per share, basic and diluted	·	·	·	·	·	5,730.00^b	49,920.00^rb	-8,970.00^rb	1,770.00^b	·
Weighted average shares, basic	679,648	9,489^r	723^r	222^rb	35^rb	24^b	309,108	686^b	667^b	667^b
Weighted average shares, diluted	679,648	9,489^r	723^r	222^rb	35^rb	24^b	·	686^b	667^b	667^b
Weighted average shares, basic and diluted	·	·	·	·	·	480^b	206^rb	171^rb	667^b	·

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-150 reverse split.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it sold

us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:Revenues

Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfRevenue

Gross profit revenue less the cost of what it soldus-gaap:GrossProfit

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

Sales and marketing the cost of finding and serving customersus-gaap:SellingAndMarketingExpense

General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense

Total operating expenses the running costs togetherus-gaap:OperatingExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing cost

us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense

Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense

Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense

Income before income taxes profit before tax

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

SI Assistanton SXTC · research, not advice